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Abstract
Consumption of a high-fat diet (HFD), which is associated with chronic ‘low-grade’ systemic inflammation, alters the gut microbiota (GM).
The aim of the present study was to investigate the ability of an oleic acid-derived compound (S1) and a combination of n-3 fatty acids
(EPA and DHA, S2) to modulate both body weight and the GM in HFD-induced obese mice. A total of eighty mice were fed either a control
diet or a HFD, non-supplemented or supplemented with S1 or S2. At week 19, faeces were collected in order to analyse the GM. Group-
specific primers for accurate quantification of several major bacterial groups from faecal samples were assayed using quantitative PCR. The
HFD induced an increase in body weight, which was reduced by supplementation with S1. Furthermore, S1 supplementation markedly
increased total bacterial density and restored the proportions of bacteria that were increased (i.e. clostridial cluster XIVa and Enterobacter-
iales) or decreased (i.e. Bifidobacterium spp.) during HFD feeding. S2 supplementation significantly increased the quantities of Firmicutes
(especially the Lactobacillus group). Correlation analysis revealed that body weight correlated positively with the phylum Firmicutes and
clostridial cluster XIVa, and negatively with the phylum Bacteroidetes. In conclusion, the consumption of a HFD induced changes in the
faecal microbiota, which were associated with the appearance of an obese phenotype. Supplementation of the HFD with S1 counteracted
HFD-induced gut dysbiosis, together with an improvement in body weight. These data support a role for certain fatty acids as interesting
nutrients related to obesity prevention.
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The worldwide prevalence of overweight and obesity has
increased dramatically in the past decades, reaching epidemic
levels(1). It is well known that a high-fat diet (HFD) leads,
especially in genetically predisposed individuals, to an
accumulation of adipose tissue(2) and to the development of
a cluster of metabolic and cardiovascular disorders such as
type 2 diabetes, atherosclerosis, hypertension and stroke(3).
The gut microbiota (GM) has an important role in supplying
nutrients and vitamins, giving colonisation resistance against
pathogenic bacteria and interacting with the host immune
system and intestinal epithelium(4). The possible involvement
of the host genotype, particularly as it relates to immunophe-
notype, has been frequently postulated as a major influence
on GM composition and stability. Other variables known to
broadly influence the composition of the GM include the
type of delivery (vaginal or caesarean), age, the use of anti-
biotics and other drugs, and ‘lifestyle’ (such as diet, physical
activity and stress)(5–9). The significance of the protective
role of the GM has been highlighted by the profound impact
seen when the GM is absent or disrupted. Germ-free mice
have poorly developed mucosal architecture and rudimentary
development of the mucosa-associated lymphoid tissue, being
generally small and underweight, and also highly susceptible
to intestinal infection(10).
In obese patients, there is a significant change in the
composition of the GM compared with lean controls(11,12),
and, in rats, these modifications can be induced by the
ingestion of a HFD(13). Furthermore, host nutritional status
may be markedly influenced by the composition and activities
of the GM since the Bacteroidetes:Firmicutes ratio seems to be
decreased in obese individuals and genetically obese mice
harbour an ‘obese microbiome’, with a transferable elevated
capacity for energy sequestration(14).
Given the important role of the GM in association with
obesity, several studies have focused on the hypothesis
that the onset of obesity may be influenced by targeted
modification of the GM by specific nutrients. Indeed, the
decrease in bifidobacteria occurring in obese mice fed with
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a HFD(15,16) was counteracted through the administration
of non-digestible oligosaccharides such as inulin-type
fructans(17).
The Mediterranean diet has been related to lower rates of
obesity(18,19). In this diet, there is a high consumption of
olive oil, which contains the MUFA oleic acid, and fish, a
rich source (especially oily fish) of n-3 PUFA. Some authors
have described the effects of oleic acid and others unsaturated
fatty acids on body weight in human and experimental
models. Vo¨gler et al.(20) evaluated the actions of C18 fatty
acids on the body weight of rats and found that oleic acid
could lead to a reduction in adipose tissue mass. In the
same study, the authors showed that 2-hydroxyoleic acid,
a synthetic derivative of oleic acid, promoted a drastic
decrease in the body weight of the treated rats(20). Moreover,
supplementation with long-chain PUFA, notably EPA and
DHA, can attenuate weight gain and reduce body fat in
rodents, particularly epididymal (visceral) fat(21). It has been
hypothesised that these fatty acids could exert their effects
by promoting changes in GM.
The aim of the present study was to evaluate the effect of a
HFD, supplemented or not with fatty acids frequently found in
the Mediterranean diet (such as oleic acid and n-3 fatty acids),
on body weight in a mouse model, and to relate that effect to
the changes in the faecal microbiota composition.
Materials and methods
Animals
A total of eighty female ICR (CD-1w) outbred mice (8 weeks
old at the beginning of the study; Harlan Laboratories) were
housed in groups of 6 ( ^ 2) animals per cage (polyurethane
boxes) and maintained at a constant temperature (22 ^ 28C)
in a controlled environment (12 h light–12 h dark cycle,
lights off at 18.00 hours), with free access to food and water.
Mice were specifically pathogen-free as tested by Harlan and
according to the Federation of European Laboratory Science
Associations recommendations. Mice were treated according
to the guidelines of the European Community Council
Directives (86/6091 EEC) as well as to the Spanish laws
about protection of animals. The experiments were performed
according to the institutional guidelines and were approved
by the Complutense University Ethical Committee for Animal
Experimentation.
Diet intervention
During the acclimatisation period (for their adaptation to
their new location), all mice were fed with a maintenance
diet (Teklad Global 14 % Protein Rodent Maintenance Diet,
reference 2014; Harlan Laboratories). At week 4, mice were
separated into four groups (three cages per group: cage A,
n 8; cage B, n 6; cage C, n 6) as follows:
(1) The control diet (CD) group continued with the mainten-
ance diet until the end of the study.
(2) The HFD group received a HFD (Adjusted Calories Diet
60/Fat, reference TD.06 414; Harlan Laboratories) until
the end of the study.
(3) The HFD-supplementation 1 (S1) group was fed for 8
weeks with the HFD, and for another 7 weeks with the
same HFD supplemented with an oleic acid-derived
compound (1500 mg/kg per d; BTSA-Biotecnologı´as
Aplicadas S.L.).
(4) The HFD-S2 group was fed for 8 weeks with the HFD, and
for another 7 weeks with the same HFD supplemented
with a combination of n-3 fatty acids (EPA and DHA,
3000 mg/kg per d; BTSA-Biotecnologı´as Aplicadas S.L.).
The full composition of both the maintenance diet and the
HFD is given in Table 1. The energy content of the mainten-
ance diet consisted of 67·3 % carbohydrate, 20·1 % protein,
12·6 % fat and 22·1 % fibre; meanwhile the HFD consisted of
21·3 % carbohydrate, 18·4 % protein, 60·3 % fat and 6·5 %
fibre. Body weight and food intake (monitored by weighing
the food provided and left uneaten, and taking into account
spillage) were recorded twice per week.
Faecal microbiota analysis
Extraction and purification of DNA from faecal samples. At
the end of the study (week 19), faeces from every cage
were collected and stored at 2808C. For analysis of the
microbial community composition, DNA was extracted from
the frozen faecal samples (cages B and C), using the
QIAampw DNA Stool Mini Kit (QIAGEN GmbH), according
to the manufacturer’s instructions, using the optional high-
temperature step (at 958C). The faecal samples were thawed
on ice; for each extraction, 471–955 mg of faeces were
weighed and diluted to 100 mg/ml with stool lysis buffer.
At the end, DNA was eluted in 200ml of elution buffer and
stored at 2208C until use.
The concentrations of the extracted DNA were determined
by a fluorometric method based on the fluorochrome
Hoechst 33 258 (Fluorescent DNA Quantification Kit; Bio-
Rad), which is fluorescent when bound to double-stranded
DNA. The measurements were performed using the Synergy
Mx Monochromator-Based Multi-Mode Microplate Reader
(Biotek Instruments) with an excitation wavelength of
360 nm and an emission wavelength of 460 nm. Data analysis
Table 1. Composition of the diets
Maintenance diet High-fat diet
Carbohydrate (%) 48·0 27·3
Protein (%) 14·3 23·5
Fat (%) 4·0 34·3
Saturated (%) 0·7 12·7
Monounsaturated (%) 0·8 16·1
Polyunsaturated (%) 2·5 5·5
Fibre (%) 22·1 6·5
Soluble (%) 4·1 –
Insoluble (%) 18·0 6·5
Energy density (kJ/g) 12·1 21·4
Energy from carbohydrate (%) 67·3 21·3
Energy from protein (%) 20·1 18·4
Energy from fat (%) 12·6 60·3
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was performed using Gen5 Software (version 1.10.8), also
supplied by Biotek Instruments.
Primers. The abundance of specific intestinal bacterial
groups was measured by quantitative PCR (qPCR) with
group-specific 16S rRNA gene primers (Isogen; Table 2). A
short segment of the 16S rRNA gene (200 bp) was specifically
amplified by qPCR, using a conserved 16S rRNA-specific
primer pair (Table 2), to determine the total amount of com-
mensal bacteria in the faeces (the so-called ‘Eubacteria/Pan-
bacteria’ group). Using the same genomic DNA from each
sample, qPCR were completed using group-specific primers
to determine the amount of bacteria in each of the following
major groups: (1) the phylum Firmicutes, the first quantitat-
ively dominant phylum in mouse faeces, which contains the
cell wall-less mycoplasmas (class Mollicutes) and the low
G þ C Gram-positive bacteria (classes Clostridia and Bacilli);
(2) clostridial cluster XIVa (the largest group of the class
Clostridia); (3) the group Lactobacillus (the so-called lactic
acid bacteria, the largest group of the order Lactobacillales,
from the class Bacilli); (4) the Gram-negative phylum
Bacteroidetes, the second quantitatively dominant phylum in
mouse faeces; (5) the order Enterobacteriales (from the
Gram-negative phylum Proteobacteria); (6) Bifidobacterium
spp. (from the high G þ C Gram-positive phylum Actino-
bacteria), one of the major genera of bacteria that make up
the colon microbiota in mice.
Quantitative PCR amplification of 16S rRNA gene
sequences. Faecal DNA samples from the four treatment
groups (n 2 animals per group) were subjected to qPCR,
which were performed to study the effect of the HFD (alone
or in combination with supplementations S1 and S2) on the
composition of the intestinal microbial community. qPCR
experiments were carried out with a Stratagene Mx3000P
(Agilent Technologies), using Mx3000Pw ninety-six-well non-
skirted PCR plates (Agilent Technologies) covered with PCR
adhesive films (Eppendorf AG). Analyses were performed in
duplicate and mean values were calculated. Each qPCR, with
a final volume of 20ml, was composed of 10ml of 2 £ Brilliant
III Ultra-Fast SYBRw Green QPCR Master Mix (Agilent Tech-
nologies), 2ml of 2mM forward primer, 2ml of 2mM reverse
primer, 0·3ml of the diluted reference dye ROX (30 nM final
concentration), 3·7ml of nuclease-free PCR-grade water and
2ml of either an optimised dilution of 1:500 of extracted tem-
plate DNA for specimen analysis or a serial dilution series of
bacterial reference genomic DNA for standard curves. All reac-
tions were paralleled by a non-template control analysis. The
amplification programme started with an initial step of 3 min at
958C, followed by thirty cycles of 15 s at 958C and 20 s at 608C.
Data were acquired in the final step at 608C.
Melt curve analysis was carried out after each qPCR assay to
distinguish the fluorescence signal obtained from the specific
amplification product from artifacts such as primer-dimers.
Melting curves were obtained by slow heating from 55 to
958C, with fluorescence measurements taken at every 18C
increase in temperature.
Data analysis was performed using MxPro–Mx3000P soft-
ware (version 4.10; Agilent Technologies). In ‘analysis term
settings’ amplification-based threshold fluorescence and
adaptive baseline correction were selected.
Preparation of PCR standards and quantification of target
bacterial DNA in faecal samples by quantitative PCR.
Standard curves for individual qPCR assays were used for
the quantification of target bacterial DNA (in relative units)
from faecal DNA preparations. The standard curves were gen-
erated using duplicate 2-fold dilutions of the DNA extracted
from the faeces of one of the cages of the CD group (cage
A, week 6). At least five non-zero standard dilutions were
used in each assay. The same amount of all faecal DNA
samples (1000 or 100 pg) was amplified by the qPCR assays,
so that the threshold cycle (CT) values were always inside
the range of the standard curves. No positive signals were
generated within the standard curves in these assays by
non-template control.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
Software for Windows OS (version 5.04; Graphpad Software).
Statistically significant differences in body weight and DNA con-
tent between the four treatment groups were determined by the
non-parametric Kruskal–Wallis test, with Dunn’s multiple com-
parison post-test. Correlations between body weight and DNA
Table 2. Primers used for bacterial quantification by quantitative PCR
Bacterial group Oligonucleotide sequence Amplicon size (bp) Reference
Total bacteria F: 50-ACTCCTACGGGAGGCAGCAG-30 200 36
R: 50-ATTACCGCGGCTGCTGG-30
Firmicutes phylum F: 50-GGAGYATGTGGTTTAATTCGAAGCA-30 126 36
R: 50-AGCTGACGACAACCATGCAC-30
Lactobacillus group F: 50-AGCAGTAGGGAATCTTCCA-30 341 14
R: 50-CACCGCTACACATGGAG-30
Clostridial cluster XIVa F: 50-GCGGTRCGGCAAGTCTGA-30 81 37
R: 50-CCTCCGACACTCTAGTMCGAC-30
Enterobacteriales order F: 50-ATGGCTGTCGTCAGCTCGT-30 177 38
R: 50-CCTACTTCTTTTGCAACCCACTC-30
Bifidobacterium spp. F: 50-TCGCGTCYGGTGTGAAAG-30 243 14
R: 50-RCCACATCCAGCRTCCAC-30
Bacteroidetes phylum F: 50-GGARCATGTGGTTTAATTCGATGAT-30 126 36
R: 50-AGCTGACGACAACCATGCAG-30
F, forward; R, reverse.
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content were assessed by the non-parametric Spearman’s corre-
lation test. P,0·05 was considered as statistically significant.
Results
Effect of the high-fat diet on mice weight
After an acclimatisation period of 4 weeks, mice were divided
into four groups: one control group fed with a maintenance
diet (CD group) and three groups fed with a HFD for
8 weeks (HFD, HFD-S1 and HFD-S2 groups). Body weight
increased progressively only in the three groups of mice that
consumed the HFD (Fig. 1(a)). The evolution of weight gain
was statistically different between the control group (CD,
mice fed with the maintenance diet) and the other three
groups (HFD, HFD-S1 and HFD-S2, mice fed with the HFD)
(Fig. 1(b)).
After diet-induced obesity, we evaluated the effect of two
different supplementations on weight gain in obese mice.
We found that S1 supplementation (an oleic acid-derived com-
pound) led to a progressive decrease in body weight
(Fig. 2(a)). This effect could not be explained by changes in
food consumption, since the total food intake was not differ-
ent between the HFD and HFD-S1 groups (data not shown).
S2 supplementation (a combination of n-3 fatty acids) did
not show any effect on mouse body weight or weight gain
(Fig. 2(a) and (b)).
Effect of the high-fat diet on total DNA content in the faeces
Compared with the control group, the HFD (non-sup-
plemented and supplemented with S2) decreased the total
DNA content in the faeces (Fig. 3(a)). However, S1 sup-
plementation was capable of increasing the total DNA content
up to a similar level to that of the control group (Fig. 3(a)).
Although these differences were not statistically significant
(P.0·1), when the total DNA content was plotted against
body weight, a significant negative correlation was observed
(Fig. 3(b)).
Effect of the high-fat diet on faecal microbiota composition
The standard curves had correlation coefficient values
ranging from 0·990 to 0·999 (Table 3). The amplification
efficiencies for the SYBR Green I assays were obtained by
plotting the CT values against the target DNA starting quantity.
Using the formula E ¼ (10(21/slope) 2 1), the efficiencies for
the individual assays ranged from 86·0 to 101·4 % (Table 3).
The fluorescence signal was not detected in the non-template
control during amplification, which indicated that the primer-
dimers were denatured at this temperature and could not con-
tribute to the fluorescence.
At the end of the study (week 19), the faecal levels of total
bacteria, Firmicutes phylum, Lactobacillus group, clostridial
cluster XIVa, Enterobacteriales order, Bifidobacterium spp.
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Fig. 1. (a) Effect of a high-fat diet (HFD) on body weight. Mice were fed for 8 weeks with either a control diet (CD) or a HFD (non-supplemented (HFD), sup-
plemented with an oleic acid-derived compound (HFD-S1) and a combination of n-3 fatty acids (HFD-S2)). Body weight was determined twice per week. Values
are means (cages B and C, n 12), with standard errors represented by vertical bars. (b) The groups’ AUC were compared by the non-parametric Kruskal–Wallis
test, with Dunn’s multiple comparison post-test. * Mean value was significantly different from that of the CD group (P,0·05).
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Fig. 2. (a) Effect of supplementation with different fatty acids on body weight. Diet-induced obese mice continued with the high-fat diet (HFD) for another 7 weeks,
non-supplemented (HFD) or supplemented with an oleic acid-derived compound (HFD-S1) or a combination of n-3 fatty acids (HFD-S2). Meanwhile, the control
diet (CD) group continued with the maintenance diet. Body weight was determined twice per week. Values are means (cages B and C, n 12), with standard errors
represented by vertical bars. (b) The groups’ AUC were compared by the non-parametric Kruskal–Wallis test, with Dunn’s multiple comparison post-test. * Mean
value was significantly different from that of the CD group (P,0·05). † Mean value was significantly different from that of the HFD-S1 group (P , 0·5).
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and Bacteroidetes phylum were determined by qPCR (Fig. 4).
The correlations between these levels and body weight were
also calculated (Fig. 5).
Total bacteria. Although not statistically significant, the
administration of the HFD induced an increase in total bacteria
when compared with control mice, an effect that was poten-
tiated by the co-administration of an oleic acid-derived com-
pound (HFD-S1), which significantly increased the total
bacteria (P,0·1; Fig. 4(a)). No correlation was found between
total bacteria and body weight (r 0·0, P¼1·0232; Fig. 5(a)).
Nevertheless, when considering DNA content per mg of
faeces, total bacteria in HFD and HFD-S2 mice were lower
than that in the control mice (data not shown), and a negative
correlation was established between total bacteria and body
weight (r 20·7143, P¼0·0576).
Bacterial groups. When compared with the CD group (fed
with the maintenance diet), the administration of the HFD
induced an increase in all the groups of Firmicutes (the
phylum Firmicutes, the Lactobacillus group and clostridial
cluster XIVa), as well as the order Enterobacteriales
(Fig. 4(b)–(e)), a difference that was statistically significant
only in the last group (P,0·1). Conversely, and although
not statistically significant, Bifidobacterium spp. and the
phylum Bacteroidetes were decreased after the ingestion of
the HFD (Fig. 4(f) and (g)).
HFD-induced microbial community changes were (partially
or completely) counteracted by the supplementation of the
HFD with an oleic acid-derived compound (HFD-S1), as
shown by the modest decrease in the phylum Firmicutes
and the group Lactobacillus (Fig. 4(b) and (c)), the significant
decrease in clostridial cluster XIVa and the order Enterobacter-
iales (Fig. 4(d) and (e)) and the significant increase in
Bifidobacterium spp. and the phylum Bacteroidetes (Fig. 4(f)
and (g)), up to a level even higher than the CD group in the last
group of bacteria.
When compared with the HFD group, supplementation
with a combination of n-3 fatty acids (HFD-S2) did not
change the levels of clostridial cluster XIVa, Bifidobacterium
spp. and the phylum Bacteroidetes (Fig. 4(d), (f) and (g)).
However, S2 supplementation was capable of increasing the
phylum Firmicutes and the group Lactobacillus, compared
with the HFD group (NS) and the CD group (P,0·1;
Fig. 4(b) and (c)). Similarly to S1 supplementation, the
increase in the order Enterobacteriales induced by the HFD
was partially restored by the S2 supplementation (Fig. 4(e)).
Although many of the mentioned differences were not stat-
istically significant (P.0·1), when the quantitative values of
the analysed microbial groups were plotted against body
weight, significant positive correlations were observed with
the phylum Firmicutes (Fig. 5(b)) and clostridial cluster XIVa
(Fig. 5(d)) and a significant negative correlation with the
phylum Bacteroidetes (Fig. 5(g)). No correlations were
found for the Lactobacillus group, the order Enterobacteriales
and Bifidobacterium spp. (Fig. 5(c), (e) and (f)).
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Fig. 3. Total DNA content and its correlation with body weight. Mice were fed with either a control diet (CD, X) or a high-fat diet (HFD), non-supplemented
(HFD, B) or supplemented with an oleic acid-derived compound (HFD-S1, O) or a combination of n-3 fatty acids (HFD-S2, V). Total DNA content is expressed as
ng DNA/mg faeces. Body weight values (g) are presented as means (cages B and C, n 6 animals per cage), with standard errors represented by vertical bars.
(b) Spearman’s correlation r 20·8810, P¼0·0072, R 2 0·8108.
Table 3. Amplification slopes, efficiencies and correlation coefficients for individual
quantitative PCR assays
PCR assay Slope PCR efficiency (%) Correlation coefficient
Total bacteria 23·288 101·4 0·999
Firmicutes phylum 23·382 97·6 0·999
Lactobacillus group 23·709 86·0 0·999
Clostridial cluster XIVa 23·439 95·3 0·999
Enterobacteriales order 23·379 97·7 0·990
Bifidobacterium spp. 23·613 90·2 0·997
Bacteroidetes phylum 23·401 96·9 0·999
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Discussion
The HFD used in the present study induced an increase of
body weight and a decrease of total DNA content in the
faeces. Supplementation of the HFD with an oleic acid-derived
compound (HFD-S1) restored both parameters up to similar
levels to that of the control group (Figs. 2(b) and 3(a)).
The GM is a complex ecosystem made up of 500–1000
different bacterial species(22), the majority of which are obli-
gate anaerobes whose investigation by culture-dependent
techniques is laborious and prone to misinterpretation(23).
Recent advances in molecular approaches to the identification
and quantification of bacteria using 16S ribosomal sequences
have significantly advanced our understanding of the GM(24).
qPCR is a powerful advancement of the basic PCR technique,
which has been successfully applied for the quantification of
bacterial DNA in various environments such as faeces, colonic
tissue, rumen, gastric tissue and periodontal samples(25). In the
present study, selected predominant bacteria from mouse
faecal samples were quantified by qPCR, using SYBR Green
I chemistry (Table 2). The DNA isolation and purification pro-
tocol yielded high-quality DNA, which was established by the
fact that increasing the total DNA template amount subjected
to qPCR did not have any inhibitory effect. This facilitates
the detection and quantification of minor subpopulations in
the faeces.
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Fig. 4. Faecal bacterial content of (a) total bacteria, (b) Firmicutes phylum, (c) Lactobacillus group, (d) clostridial cluster XIVa, (e) Enterobacteriales order, (f) Bifi-
dobacterium spp. and (g) Bacteroidetes phylum. Bacterial quantities are expressed as relative units. Mice were fed with either a control diet (CD, X) or a HFD,
non-supplemented (HFD, B) or supplemented with an oleic acid-derived compound (HFD-S1, O) or a combination of n-3 fatty acids (HFD-S2, V). * Mean value
was significantly different from that of the CD group (P,0·1; Kruskal–Wallis).
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Fig. 5. Correlation between body weight and the faecal bacterial content of (a) total bacteria (Spearman’s r 0·0, P¼1·0232 (NS), R 2 0·0329), (b) Firmicutes phy-
lum (Spearman’s r 0·8333, P¼0·0154, R 2 0·7424), (c) Lactobacillus group (Spearman’s r 0·6429, P¼0·0962 (NS), R 2 0·1897), (d) clostridial cluster XIVa (Spear-
man’s r 0·9286, P¼0·0022, R 2 0·5072), (e) Enterobacteriales order (Spearman’s r 0·5952, P¼0·1323 (NS), R 2 0·3643), (f) Bifidobacterium spp. (Spearman’s
r 20·5538, P¼0·1966 (NS), R 2 0·2453) and (g) Bacteroidetes phylum (Spearman’s r 20·7857, P¼0·0279, R 2 0·5678). Mice were fed with either a control diet
(CD, X) or a HFD, non-supplemented (HFD, B) or supplemented with an oleic acid-derived compound (HFD-S1, O) or a combination of n-3 fatty acids (HFD-S2,
V). Bacterial quantities are expressed as relative units. Body weight values (g) are presented as means (cages B and C, n 6 animals per cage), with standard
errors represented by vertical bars.
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Animal and human studies have revealed a remarkable
microbial influence on host metabolism, energy utilisation
and storage, and metabolic diseases(26–29). However, this com-
plex ecosystem remains poorly studied; therefore, more
precise monitoring of the gut bacteria is vital for better under-
standing of their contribution to health and disease.
Recently, it has been proposed that alterations in the
composition of the GM (known as dysbiosis) participate in
the development of obesity(30). In the present study, adminis-
tration of a HFD induced a significant increase in the Entero-
bacteriales order (P,0·1; Fig. 4(e)). A bloom in the
g-Proteobacteria class, to which belongs the Enterobacteriales
order, was also observed in the study of Hildebrandt et al.(31).
An increase in the Enterobacteriaceae family within this order
has been associated with gut inflammation; induction of
experimental colitis in rodents was followed by an increase
in this family, suggesting that it may be a consequence of
gut inflammation rather than a cause(32).
More than 90 % of the distal GM of mice and humans is
composed of the Bacteroidetes and Firmicutes phyla(31),
while other members, such as lactic acid bacteria and Proteo-
bacteria, are present in much lower amounts(33). Similar to
previously reported well-defined experiments using in part
even genetically modified animals(34) or strictly controlled
human studies(14,35), administration of a HFD induced an
increase in all the groups of Firmicutes (the phylum Firmi-
cutes, the group Lactobacillus and clostridial cluster XIVa;
Fig. 4(b)–(d)) and a decrease in the phylum Bacteroidetes
(Fig. 4(g)). However, further reports have linked an increased
proportion of Bacteroidetes in obese rats(13) and human sub-
jects(9,36,37). The most probable explanation for this discre-
pancy could be that some of these studies did not control
for other possible confounding variables of obesity, such as
intensity, regularity of exercise as well as total daily energy
intake(37). Methodological differences in DNA extraction pro-
tocols, primer design and qPCR techniques may also have
caused additional variation. Either way, obesity seems to be
related to changes in the Firmicutes:Bacteroidetes ratio that
could be involved in a greater capacity to extract energy
from nutrients(38,39).
The compositions of the diets employed in the present
study are probably responsible for some changes related to
the GM composition. According to the manufacturer, the CD
contains cereal products that contribute to 18·0 % of insoluble
fibre (including cellulose, hemicellulose and lignin) and 4·1 %
of soluble fibre (including fermentable carbohydrates). In con-
trast, the HFD has much less fibre (6·5 %), which is exclusively
obtained from cellulose, a poorly fermentable insoluble fibre.
The absence of soluble fibre in the HFD could explain the
lower levels of Bifidobacterium spp. (Fig. 4(f)).
Supplementation of the HFD with S1 markedly increased
total bacterial density and restored the proportions of
bacteria that were increased (i.e. clostridial cluster XIVa and
Enterobacteriales) or decreased (i.e. Bifidobacterium spp.)
during HFD feeding (Fig. 4(d)–(f)). The decrease in body
weight only in the HFD group supplemented with an oleic
acid-derived compound (S1) could be explained by the
decrease in the Firmicutes:Bacteroidetes ratio up to a level
even lower than the CD group, but a combination of n-3
fatty acids (S2) did not.
The HFD-induced levels of clostridial cluster XIVa, Bifido-
bacterium spp. and the phylum Bacteroidetes were not
restored by supplementation with a combination of n-3 fatty
acids (HFS-S2; Fig. 4(d), (f), and (g)). However, the elevated
number of Enterobacteriales induced by the HFD, and prob-
ably associated with gut inflammation, was partially restored
by S2 supplementation (Fig. 4(e)), which are well-known
modulators of the inflammatory process(40).
n-3 PUFA influence the gastrointestinal microbiota and
specifically the population level of lactic acid bacteria
(mainly bifidobacteria and lactobacilli), which are generally
considered to be beneficial. A study carried out in fish has
reported an increase in the content of lactobacilli by n-3
PUFA consumption(41). According to Kankaanpaa et al.(42),
low concentrations of n-3 fatty acids (5mg/ml) promoted
growth and mucus adhesion of Lactobacillus casei Shirota.
In gnotobiotic piglets, the oral administration of an oil contain-
ing PUFA significantly increased the number of Lactobacillus
paracasei adhering to the jejunal mucosa compared with the
control group(43). Moreover, mice fed with a diet depleted in
n-3 PUFA for two generations exhibited a huge decrease in
lactobacilli and, unexpectedly, an increase in bifidobacteria
in the caecal content when compared with mice fed a diet
with an adequate content in n-3 PUFA(44). Coherently, we
show here in mice that S2 supplementation increased the
quantities of Firmicutes (especially the Lactobacillus group),
when compared with the HFD (NS) and CD groups (P,0·1;
Fig. 4(b) and (c)).
The adhesion to mucosal surfaces is pivotal in health-
promoting effects by probiotics. Although further studies are
needed to confirm this hypothesis in vivo, evidence suggests
that some physiological effects of probiotics could be associ-
ated with the interactions between probiotics and dietary
PUFA. It has been suggested that dietary PUFA affect the
attachment sites for the gastrointestinal microbiota, possibly
by modifying the fatty acid composition of the intestinal
wall(41–43). The stimulatory effect of PUFA upon adhesion
of lactobacilli could be used for enhancing the effectiveness
of probiotics in inhibiting digestive tract pathogens.
Conclusions
Consumption of a HFD induced changes in the faecal
microbiota (an increase in all the tested groups of Firmicutes,
as well as the order Enterobacteriales, and a decrease in
Bifidobacterium spp. and the phylum Bacteroidetes), which
were associated with the appearance of an obese phenotype.
Correlation analysis revealed that body weight correlated
positively with the phylum Firmicutes and clostridial cluster
XIVa, and negatively with the phylum Bacteroidetes. Sup-
plementation of the HFD with S1 counteracted HFD-induced
gut dysbiosis, together with an improvement in body weight.
These data support a role for certain fatty acids as interest-
ing nutrients related to obesity prevention. Even if a direct
extrapolation of the present study to humans is still question-
able due to differences in digestive tract structure and in GM,
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the present findings support the view that chronic consump-
tion of an oleic acid-derived compound (S1) could confer
potential beneficial effects with respect to the development
of obesity, through a mechanism related to the restoration of
the composition of gut bacteria. The possibility to treat ani-
mals with selected bacteria as oral probiotics could also con-
stitute one interesting perspective to investigate further on
the role of these specific gut bacteria in HFD-induced obesity.
However, and until these issues are clarified, the best way to
prevent obesity in humans is by promoting a healthy diet
and lifestyle.
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